Freeze-Dried RT-PCR Test Reagent Kit Of COVID-19(ORF1ab,N)

Introducing our Novel Coronavirus Testing Reagent, a reliable and accurate solution for detecting the presence of the virus. This high-quality reagent has been specifically designed to provide quick and efficient results, making it an essential tool in the fight against the pandemic. With its user-friendly design, it can be easily used by healthcare professionals and laboratories alike. Our testing reagent ensures utmost precision, reducing the chances of false negatives or positives. Trust in our product to deliver accurate and timely results, aiding in the identification and containment of the virus. Stay safe and protected with our Novel Coronavirus Testing Reagent.

View:

 

Freeze-dried Novel Coronavirus Test Reagent(ORF1ab,N)

Brand: Uni-medica

Packaging: export standard

Supply Ability: 10 000 000 000 reactions/year

[Product Name] Freeze-dried Novel Coronavirus Test ReagentFreeze-Dried Real Time PCR Kit for Novel Coronavirus 2019-nCoV [Alternative Name] Novel Coronavirus Test Reagent, also named Freeze-dried Pcr Test Reagent, etc. [Product Description] The...

Contact Now

Freeze-Dried Real Time PCR Kit for Novel Coronavirus 2019-nCoV (ORF1ab, N)

Brand: Uni-medica

Packaging: export standard

Supply Ability: 1000000000000

This freeze-dried novel coronavirus (COVID-19) test kit(it is also called) SARS-CoV-2(2019-nCoV) multiplex qRT-PCR kit is a qualitative real-time reverse transcription polymerase chain reaction (RT-PCR) assay intended to be used for the nucleic acid...

Contact Now

Home > Products > PCR Test Reagent Kit Related With COVID-19 > Freeze-Dried RT-PCR Test Reagent Kit Of COVID-19(ORF1ab,N)

China Freeze-Dried RT-PCR Test Reagent Kit Of COVID-19(ORF1ab,N) Suppliers

The Freeze-Dried RT-PCR Test Reagent Kit is a real-time reverse transcriptase (RT)-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum from individuals suspected of COVID-19 by their healthcare provider. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection.

Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. The agent detected may not be the definite cause of disease. Positive results do not rule out bacterial infection or co-infection with other viruses.

Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.